×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Skip to main content
Tags: fda | antibody | test | policy | pandemic

FDA Reverses, Manufacturers Must Prove Antibody Test Accuracy

a face mask lays on a blue table with a vile for a test and a syringe lay on the top
(Oleksandr Lutsenko/Dreamstime)

By    |   Monday, 04 May 2020 05:08 PM

The Food and Drug Administration has reversed its stance and will now require commercial manufacturers to submit data that proves their antibody tests for the coronavirus are accurate.

Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs, and Jeff Shuren, M.D., Director, Center for Devices and Radiological Health announced in a blog post Sunday the FDA has updated the policy that made over 100 antibody tests available on the market without prior review by the agency. The note that the initial policy allowed for "a higher level of flexibility" than is necessary now.

The new policy requires "commercial manufacturers will submit EUA [emergency use authorization] requests, with their validation data, within 10 business days from the date they notified the FDA of their validation testing OR from the date of this policy, whichever is later. Furthermore, the FDA has provided specific performance threshold recommendations for specificity and sensitivity for all serology test developers."

The FDA also announced the agency is "introducing a more streamlined process to support EUA submissions and review. Two voluntary EUA templates for antibody tests have been made available – one for commercial manufacturers," and one for high-complexity labs that have been certified by the Centers for Medicare and Medicaid Services to conduct testing.

"The FDA will continue to take steps to appropriately balance assurances that an antibody test is accurate and reliable with timely access to such tests as the continually evolving circumstances and public health needs warrant," Shah and Shuren conclude.

© 2022 Newsmax. All rights reserved.


US
The Food and Drug Administration has reversed its stance and will now require commercial manufacturers to submit data that proves their antibody tests for the coronavirus are accurate.
fda, antibody, test, policy, pandemic
247
2020-08-04
Monday, 04 May 2020 05:08 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved